- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Product Innovation & Availability
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Monday, May 18, 2020
HIV represents one of the most challenging viruses ever encountered. Though an HIV vaccine has yet to be licensed, vaccine science has made enormous strides as it confronts this rapidly-mutating virus. Years of painstaking work to develop accines for HIV are now making possible the record-breaking timelines that researchers aspire to for the development of COVID-19 vaccines. HIV vaccine research has generated more scientific knowledge about immune function and responses than ever existed. And key HIV vaccine platforms are fast-tracking the development and testing of experimental vaccines for COVID-19 today.
Excerpted from Five "P"s to Watch.